Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AUROBINDO PHARMA vs SUPRIYA LIFESCIENCE - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AUROBINDO PHARMA SUPRIYA LIFESCIENCE AUROBINDO PHARMA/
SUPRIYA LIFESCIENCE
 
P/E (TTM) x 22.7 23.4 97.2% View Chart
P/BV x 2.4 4.0 58.4% View Chart
Dividend Yield % 0.3 0.2 162.4%  

Financials

 AUROBINDO PHARMA   SUPRIYA LIFESCIENCE
EQUITY SHARE DATA
    AUROBINDO PHARMA
Mar-23
SUPRIYA LIFESCIENCE
Mar-23
AUROBINDO PHARMA/
SUPRIYA LIFESCIENCE
5-Yr Chart
Click to enlarge
High Rs715515 138.7%   
Low Rs397170 233.6%   
Sales per share (Unadj.) Rs424.250.4 842.1%  
Earnings per share (Unadj.) Rs32.911.2 294.7%  
Cash flow per share (Unadj.) Rs54.112.6 428.5%  
Dividends per share (Unadj.) Rs3.000.60 500.0%  
Avg Dividend yield %0.50.2 308.2%  
Book value per share (Unadj.) Rs458.186.9 527.1%  
Shares outstanding (eoy) m585.9480.48 728.1%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x1.36.8 19.3%   
Avg P/E ratio x16.930.7 55.1%  
P/CF ratio (eoy) x10.327.1 37.9%  
Price / Book Value ratio x1.23.9 30.8%  
Dividend payout %9.15.4 169.7%   
Avg Mkt Cap Rs m325,75327,581 1,181.1%   
No. of employees `000NANA-   
Total wages/salary Rs m35,223556 6,337.4%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m248,5544,054 6,131.0%  
Other income Rs m2,906100 2,908.5%   
Total revenues Rs m251,4604,154 6,053.5%   
Gross profit Rs m37,0701,284 2,886.1%  
Depreciation Rs m12,446118 10,533.9%   
Interest Rs m1,40531 4,485.3%   
Profit before tax Rs m26,1251,235 2,115.6%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6,849336 2,036.4%   
Profit after tax Rs m19,277899 2,145.2%  
Gross profit margin %14.931.7 47.1%  
Effective tax rate %26.227.2 96.3%   
Net profit margin %7.822.2 35.0%  
BALANCE SHEET DATA
Current assets Rs m214,5994,649 4,616.1%   
Current liabilities Rs m114,938958 12,000.1%   
Net working cap to sales %40.191.0 44.0%  
Current ratio x1.94.9 38.5%  
Inventory Days Days2124 87.3%  
Debtors Days Days6676 86.0%  
Net fixed assets Rs m176,6683,554 4,971.1%   
Share capital Rs m586161 364.0%   
"Free" reserves Rs m267,8136,834 3,919.0%   
Net worth Rs m268,3996,995 3,837.2%   
Long term debt Rs m6,1900-   
Total assets Rs m392,1258,203 4,780.4%  
Interest coverage x19.640.4 48.5%   
Debt to equity ratio x00-  
Sales to assets ratio x0.60.5 128.3%   
Return on assets %5.311.3 46.5%  
Return on equity %7.212.8 55.9%  
Return on capital %10.018.1 55.4%  
Exports to sales %33.788.8 37.9%   
Imports to sales %15.323.5 65.1%   
Exports (fob) Rs m83,7033,598 2,326.3%   
Imports (cif) Rs m38,060953 3,992.9%   
Fx inflow Rs m85,4833,598 2,375.8%   
Fx outflow Rs m41,447953 4,348.3%   
Net fx Rs m44,0362,645 1,664.9%   
CASH FLOW
From Operations Rs m23,868662 3,606.1%  
From Investments Rs m-39,778-1,331 2,987.6%  
From Financial Activity Rs m18,144-34 -53,888.0%  
Net Cashflow Rs m2,298-703 -326.7%  

Share Holding

Indian Promoters % 48.8 68.3 71.4%  
Foreign collaborators % 3.1 0.0 -  
Indian inst/Mut Fund % 41.3 10.0 415.3%  
FIIs % 20.7 4.6 454.4%  
ADR/GDR % 0.0 0.0 -  
Free float % 48.2 31.7 152.0%  
Shareholders   241,944 95,929 252.2%  
Pledged promoter(s) holding % 20.1 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AUROBINDO PHARMA With:   CIPLA    SUN PHARMA    LUPIN    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on Aurobindo Pharma vs SUPRIYA LIFESCIENCE

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

Aurobindo Pharma vs SUPRIYA LIFESCIENCE Share Price Performance

Period Aurobindo Pharma SUPRIYA LIFESCIENCE S&P BSE HEALTHCARE
1-Day 4.96% 1.04% 0.79%
1-Month 1.04% 18.29% 3.52%
1-Year 132.62% 73.41% 61.40%
3-Year CAGR 6.71% -3.58% 17.85%
5-Year CAGR 7.92% -2.16% 20.06%

* Compound Annual Growth Rate

Here are more details on the Aurobindo Pharma share price and the SUPRIYA LIFESCIENCE share price.

Moving on to shareholding structures...

The promoters of Aurobindo Pharma hold a 51.8% stake in the company. In case of SUPRIYA LIFESCIENCE the stake stands at 68.3%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of Aurobindo Pharma and the shareholding pattern of SUPRIYA LIFESCIENCE .

Finally, a word on dividends...

In the most recent financial year, Aurobindo Pharma paid a dividend of Rs 3.0 per share. This amounted to a Dividend Payout ratio of 9.1%.

SUPRIYA LIFESCIENCE paid Rs 0.6, and its dividend payout ratio stood at 5.4%.

You may visit here to review the dividend history of Aurobindo Pharma, and the dividend history of SUPRIYA LIFESCIENCE .

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex, Nifty Hit Fresh Record High | Metal Stocks Shine in Special Trading Session | Tata Steel, SAIL, JSW Steel Up 3% Sensex, Nifty Hit Fresh Record High | Metal Stocks Shine in Special Trading Session | Tata Steel, SAIL, JSW Steel Up 3%(Closing)

Indian share markets traded marginally higher throughout the special trading sessions today and ended on a positive note.